As Panel Urges Gov't to Regulate Pathogen Gene Sequences, Genomic Industry Frets Over Innovation | GenomeWeb
NEW YORK (GenomeWeb News) — A federal government advisory board, eager to ensure that advances in synthetic genomics do not become components of bioterrorism, is recommending that the government regulate gene sequences of pathogens rather than simply regulating the pathogens themselves.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.